2010
DOI: 10.1002/ptr.3171
|View full text |Cite
|
Sign up to set email alerts
|

NFκB: a promising target for natural products in cancer chemoprevention

Abstract: The transcription factor nuclear factor kappa B (NFκB) is found in nearly all animal cell types. It is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL and microbial antigens, and has been shown to regulate the expression of a number of genes including bcl-2, bcl-xl, cIAP, suvivin, TRAF, COX-2, MMP-9, iNOS and cell cycle-regulatory components. Many carcinogens, infl ammatory agents and tumor promoters have been shown to activate NFκB, and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
122
0
3

Year Published

2011
2011
2022
2022

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 179 publications
(125 citation statements)
references
References 194 publications
(138 reference statements)
0
122
0
3
Order By: Relevance
“…NF-κB can modulate the transcriptional activation of genes associated with cell proliferation, angiogenesis, metastasis, tumor promotion and suppression of apoptosis (Lugman and Pezzuto, 2010). Researches have shown that disregulation of NF-κB transcription machinery is one of the factors thought to be common early events in malignant tumor progression (Meng et al, 2012).…”
Section: Discussionmentioning
confidence: 99%
“…NF-κB can modulate the transcriptional activation of genes associated with cell proliferation, angiogenesis, metastasis, tumor promotion and suppression of apoptosis (Lugman and Pezzuto, 2010). Researches have shown that disregulation of NF-κB transcription machinery is one of the factors thought to be common early events in malignant tumor progression (Meng et al, 2012).…”
Section: Discussionmentioning
confidence: 99%
“…As a result of its key role in several pathologic conditions, NF-κB is a major drug target in a variety of diseases. The blockade of NF-κB transcriptional activity in microglial is also known to suppress expression of iNOS, COX-2, pro-inflammatory cytokines and chemokines including TNF-α, IL-1β and MCP-1 (38)(39)(40). Therefore, many putative anti-inflammatory therapies seek to block NF-κB activity.…”
Section: Discussionmentioning
confidence: 99%
“…The blockade of NF-κB transcriptional activity is also known to suppress expression of pro-inflammatory mediators including iNOS, COX-2, and IL-1β (37)(38)(39). Therefore, downregulation of NF-κB activity is a useful strategy to regulate inflammatory diseases.…”
Section: Discussionmentioning
confidence: 99%